ID   NUCB1_RAT               Reviewed;         459 AA.
AC   Q63083; P97623; Q497A4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   24-JUL-2024, entry version 156.
DE   RecName: Full=Nucleobindin-1;
DE   AltName: Full=Bone 63 kDa calcium-binding protein;
DE   AltName: Full=CALNUC;
DE   Flags: Precursor;
GN   Name=Nucb1; Synonyms=Nuc;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Bone;
RX   PubMed=7890746; DOI=10.1074/jbc.270.11.6125;
RA   Wendel M., Sommarin Y., Bergman T., Heinegaard D.;
RT   "Isolation, characterization, and primary structure of a calcium-binding
RT   63-kDa bone protein.";
RL   J. Biol. Chem. 270:6125-6133(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Long X., Bigsby R.M., Nephew K.P.;
RT   "Rat nucleobindin mRNA, complete cds and including 3' UTR.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 351-425.
RC   STRAIN=Wistar Kyoto; TISSUE=Aortic smooth muscle;
RA   Adams L.A., Werny I., Schwartz S.M.;
RL   Submitted (OCT-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9647645; DOI=10.1083/jcb.141.7.1515;
RA   Lin P., Le-Niculescu H., Hofmeister R., McCaffery J.M., Jin M.,
RA   Hennemann H., McQuistan T., De Vries L., Farquhar M.G.;
RT   "The mammalian calcium-binding protein, nucleobindin (CALNUC), is a Golgi
RT   resident protein.";
RL   J. Cell Biol. 141:1515-1527(1998).
RN   [6]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH GNAI3.
RX   PubMed=10639138; DOI=10.1073/pnas.97.2.674;
RA   Lin P., Fischer T., Weiss T., Farquhar M.G.;
RT   "Calnuc, an EF-hand Ca(2+) binding protein, specifically interacts with the
RT   C-terminal alpha5-helix of G(alpha)i3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:674-679(2000).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-368, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [8]
RP   FUNCTION, INTERACTION WITH GNAI1; GNAI2 AND GNAI3, GBA MOTIF, AND
RP   MUTAGENESIS OF LEU-313; PHE-316 AND LEU-317.
RX   PubMed=21653697; DOI=10.1074/jbc.m110.204099;
RA   Garcia-Marcos M., Kietrsunthorn P.S., Wang H., Ghosh P., Farquhar M.G.;
RT   "G Protein binding sites on Calnuc (nucleobindin 1) and NUCB2 (nucleobindin
RT   2) define a new class of G(alpha)i-regulatory motifs.";
RL   J. Biol. Chem. 286:28138-28149(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85 AND SER-368, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Major calcium-binding protein of the Golgi which may have a
CC       role in calcium homeostasis (PubMed:7890746). Acts as a non-receptor
CC       guanine nucleotide exchange factor which binds to and activates alpha
CC       subunits of guanine nucleotide-binding proteins (G proteins)
CC       (PubMed:21653697). {ECO:0000269|PubMed:21653697,
CC       ECO:0000269|PubMed:7890746}.
CC   -!- SUBUNIT: Interacts (via GBA motif) with guanine nucleotide-binding
CC       protein G(i) alpha subunits GNAI1, GNAI2 and GNAI3 with higher affinity
CC       for GNAI1 and GNAI3 than for GNAI2 (PubMed:10639138, PubMed:21653697).
CC       Preferentially interacts with inactive rather than active GNAI3
CC       (PubMed:21653697). Interaction with GNAI3 is inhibited when NUCB1 binds
CC       calcium, probably due to a conformational change which renders the GBA
CC       motif inaccessible (PubMed:21653697). {ECO:0000269|PubMed:10639138,
CC       ECO:0000269|PubMed:21653697}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, cis-Golgi network membrane
CC       {ECO:0000269|PubMed:10639138, ECO:0000269|PubMed:9647645}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:9647645}; Lumenal side
CC       {ECO:0000269|PubMed:9647645}. Cytoplasm {ECO:0000269|PubMed:10639138,
CC       ECO:0000269|PubMed:9647645}. Secreted {ECO:0000269|PubMed:7890746}.
CC       Note=A small fraction of the protein may be cytoplasmic. In bone at
CC       least part of it is found in the extracellular matrix and in the
CC       culture medium of calvaria explants. {ECO:0000269|PubMed:7890746,
CC       ECO:0000269|PubMed:9647645}.
CC   -!- TISSUE SPECIFICITY: Minor constituent of the mineralized matrix of
CC       bone. Detected in calvaria, rib cartilage, liver, kidney, spleen,
CC       brain, lung, skeletal and heart muscle with highest expression in
CC       calvaria and approximately half the amount in kidney, liver and brain.
CC       {ECO:0000269|PubMed:7890746}.
CC   -!- DOMAIN: The EF-hand domains are unfolded in the absence of Ca(2+) and
CC       fold upon Ca(2+) addition. {ECO:0000250|UniProtKB:Q02818}.
CC   -!- DOMAIN: The GBA (G-alpha binding and activating) motif mediates binding
CC       to the alpha subunits of guanine nucleotide-binding proteins (G
CC       proteins). {ECO:0000269|PubMed:21653697}.
CC   -!- MISCELLANEOUS: Discovered as DNA-binding protein in the serum of lupus-
CC       prone mice.
CC   -!- SIMILARITY: Belongs to the nucleobindin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z36277; CAA85285.1; -; mRNA.
DR   EMBL; U75409; AAB19111.1; -; mRNA.
DR   EMBL; BC100643; AAI00644.1; -; mRNA.
DR   EMBL; AF336828; AAK21297.1; -; mRNA.
DR   PIR; I55472; I55472.
DR   RefSeq; NP_445915.1; NM_053463.1.
DR   RefSeq; XP_006229227.1; XM_006229165.1.
DR   AlphaFoldDB; Q63083; -.
DR   BMRB; Q63083; -.
DR   SMR; Q63083; -.
DR   BioGRID; 250025; 2.
DR   IntAct; Q63083; 3.
DR   STRING; 10116.ENSRNOP00000028390; -.
DR   iPTMnet; Q63083; -.
DR   PhosphoSitePlus; Q63083; -.
DR   jPOST; Q63083; -.
DR   PaxDb; 10116-ENSRNOP00000028390; -.
DR   GeneID; 84595; -.
DR   KEGG; rno:84595; -.
DR   UCSC; RGD:620030; rat.
DR   AGR; RGD:620030; -.
DR   CTD; 4924; -.
DR   RGD; 620030; Nucb1.
DR   VEuPathDB; HostDB:ENSRNOG00000020889; -.
DR   eggNOG; KOG3866; Eukaryota.
DR   HOGENOM; CLU_031153_1_0_1; -.
DR   InParanoid; Q63083; -.
DR   OrthoDB; 603296at2759; -.
DR   PhylomeDB; Q63083; -.
DR   TreeFam; TF323218; -.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   PRO; PR:Q63083; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000020889; Expressed in cerebellum and 19 other cell types or tissues.
DR   GO; GO:0005769; C:early endosome; IDA:RGD.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0090498; C:extrinsic component of Golgi membrane; IDA:RGD.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IDA:RGD.
DR   GO; GO:0005798; C:Golgi-associated vesicle; IDA:RGD.
DR   GO; GO:0098547; C:lumenal side of Golgi membrane; IDA:RGD.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IDA:RGD.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; IDA:UniProtKB.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB.
DR   GO; GO:1903533; P:regulation of protein targeting; IDA:RGD.
DR   GO; GO:0007264; P:small GTPase-mediated signal transduction; IDA:UniProtKB.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR040250; Nucleobindin.
DR   PANTHER; PTHR19237; NUCLEOBINDIN; 1.
DR   PANTHER; PTHR19237:SF21; NUCLEOBINDIN-1; 1.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   Calcium; Coiled coil; Cytoplasm; DNA-binding; Golgi apparatus;
KW   Guanine-nucleotide releasing factor; Membrane; Metal-binding;
KW   Phosphoprotein; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000250|UniProtKB:Q0P569"
FT   CHAIN           26..459
FT                   /note="Nucleobindin-1"
FT                   /id="PRO_0000004164"
FT   DOMAIN          239..274
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          291..326
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DNA_BIND        171..217
FT                   /evidence="ECO:0000255"
FT   REGION          192..220
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          227..320
FT                   /note="Binds to GNAI2 and GNAI3"
FT   REGION          393..459
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          149..217
FT                   /evidence="ECO:0000255"
FT   COILED          340..407
FT                   /evidence="ECO:0000255"
FT   MOTIF           302..332
FT                   /note="GBA"
FT                   /evidence="ECO:0000250|UniProtKB:Q02818"
FT   COMPBIAS        192..218
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        393..417
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         252
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         254
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         256
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         263
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         304
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         306
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         308
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         315
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   MOD_RES         85
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         147
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q02818"
FT   MOD_RES         368
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         456
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q02819"
FT   MUTAGEN         313
FT                   /note="L->A: Decreased binding to GNAI3. Further decrease
FT                   in binding to GNAI3 and loss of GNAI3 activation; when
FT                   associated with A-317."
FT                   /evidence="ECO:0000269|PubMed:21653697"
FT   MUTAGEN         316
FT                   /note="F->A: Decreased binding to GNAI3 and impaired GNAI3
FT                   activation."
FT                   /evidence="ECO:0000269|PubMed:21653697"
FT   MUTAGEN         317
FT                   /note="L->A: Decreased binding to GNAI3. Further decrease
FT                   in binding to GNAI3 and loss of GNAI3 activation; when
FT                   associated with A-313."
FT                   /evidence="ECO:0000269|PubMed:21653697"
SQ   SEQUENCE   459 AA;  53507 MW;  862BC82673002949 CRC64;
     MPTSVPRGAP FLLLPPLLML SAVLAVPVDR AAPHQEDNQA TETPDTGLYY HRYLQEVINV
     LETDGHFREK LQAANAEDIK SGKLSQELDF VSHNVRTKLD ELKRQEVSRL RMLLKAKMDA
     KQEPNLQVDH MNLLKQFEHL DPQNQHTFEA RDLELLIQTA TRDLAQYDAA HHEEFKRYEM
     LKEHERRRYL ESLGEEQRKE AERKLQEQQR RHREHPKVNV PGSQAQLKEV WEELDGLDPN
     RFNPKTFFIL HDINSDGVLD EQELEALFTK ELEKVYDPKN EEDDMREMEE ERLRMREHVM
     KNVDTNQDRL VTLEEFLAST QRKEFGETAE GWKTVEMYPA YTEEELKRFE EELAAREAEL
     NARAQRLSQE TEALGRSQDR LEAQKRELQQ AVLQMEQRKQ QQQEQSAPPS QPDGQLQFRA
     DTGDAPVPAP AGDQKDVPAS EKKVPEQPPV LPQLDSQHL
//
